Market Closed -
Nyse
04:00:01 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
50.75
USD
|
-1.19%
|
|
-1.19%
|
+12.23%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
6,015
|
4,672
|
5,023
|
8,163
|
8,820
|
9,740
|
-
|
-
|
Enterprise Value (EV)
1 |
6,015
|
7,821
|
8,391
|
11,473
|
8,820
|
9,740
|
9,740
|
9,740
|
P/E ratio
|
5.56
x
|
5.9
x
|
6.11
x
|
6.31
x
|
6.96
x
|
6.46
x
|
6.05
x
|
5.52
x
|
Yield
|
3.74%
|
4.97%
|
4.76%
|
3.07%
|
-
|
3.05%
|
3.34%
|
3.83%
|
Capitalization / Revenue
|
0.5
x
|
0.39
x
|
0.42
x
|
0.68
x
|
0.71
x
|
0.75
x
|
0.72
x
|
0.7
x
|
EV / Revenue
|
0.5
x
|
0.39
x
|
0.42
x
|
0.68
x
|
0.71
x
|
0.75
x
|
0.72
x
|
0.7
x
|
EV / EBITDA
|
3,553,160
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
3.93
x
|
-
|
-
|
8.85
x
|
7.49
x
|
-
|
FCF Yield
|
-
|
-
|
25.4%
|
-
|
-
|
11.3%
|
13.3%
|
-
|
Price to Book
|
0.59
x
|
0.43
x
|
0.44
x
|
0.88
x
|
0.91
x
|
0.9
x
|
0.81
x
|
0.72
x
|
Nbr of stocks (in thousands)
|
206,268
|
203,662
|
204,453
|
198,941
|
195,046
|
191,922
|
-
|
-
|
Reference price
2 |
29.16
|
22.94
|
24.57
|
41.03
|
45.22
|
50.75
|
50.75
|
50.75
|
Announcement Date
|
2/4/20
|
2/4/21
|
2/1/22
|
1/31/23
|
1/30/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
12,022
|
11,963
|
11,937
|
12,007
|
12,422
|
12,961
|
13,464
|
13,927
|
EBITDA
|
1,693
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
1,583
|
1,443
|
1,302
|
1,744
|
2,127
|
2,073
|
2,148
|
-
|
Operating Margin
|
13.16%
|
12.06%
|
10.9%
|
14.53%
|
17.12%
|
16%
|
15.95%
|
-
|
Earnings before Tax (EBT)
1 |
1,382
|
-
|
-
|
-
|
1,640
|
1,942
|
1,978
|
2,019
|
Net income
1 |
1,100
|
793
|
824.2
|
1,314
|
1,284
|
1,508
|
1,533
|
1,582
|
Net margin
|
9.15%
|
6.63%
|
6.9%
|
10.95%
|
10.33%
|
11.63%
|
11.39%
|
11.36%
|
EPS
2 |
5.240
|
3.890
|
4.020
|
6.500
|
6.500
|
7.859
|
8.394
|
9.193
|
Free Cash Flow
1 |
-
|
-
|
1,277
|
-
|
-
|
1,100
|
1,300
|
-
|
FCF margin
|
-
|
-
|
10.7%
|
-
|
-
|
8.49%
|
9.66%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
154.96%
|
-
|
-
|
72.95%
|
84.78%
|
-
|
Dividend per Share
2 |
1.090
|
1.140
|
1.170
|
1.260
|
-
|
1.549
|
1.697
|
1.944
|
Announcement Date
|
2/4/20
|
2/4/21
|
2/1/22
|
1/31/23
|
1/30/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
2,970
|
2,988
|
2,996
|
3,045
|
2,966
|
2,999
|
3,036
|
3,111
|
3,124
|
3,151
|
3,204
|
3,241
|
3,258
|
3,283
|
3,317
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
305.7
|
270.7
|
389.5
|
511.2
|
428
|
416.8
|
517.4
|
567.3
|
538.8
|
503.3
|
514.3
|
517.9
|
544
|
544
|
-
|
Operating Margin
|
10.29%
|
9.06%
|
13%
|
16.79%
|
14.43%
|
13.9%
|
17.04%
|
18.23%
|
17.25%
|
15.97%
|
16.05%
|
15.98%
|
16.7%
|
16.57%
|
-
|
Earnings before Tax (EBT)
1 |
409.9
|
191.7
|
312.1
|
443.1
|
515.3
|
360.9
|
451.3
|
498.4
|
261.7
|
428.7
|
483
|
487
|
483
|
488
|
492
|
Net income
1 |
328.6
|
159.7
|
253.5
|
370.4
|
410.7
|
279.6
|
358.3
|
392.9
|
202
|
330.6
|
372.3
|
380.6
|
383
|
378.8
|
389.8
|
Net margin
|
11.06%
|
5.35%
|
8.46%
|
12.16%
|
13.85%
|
9.32%
|
11.8%
|
12.63%
|
6.47%
|
10.49%
|
11.62%
|
11.74%
|
11.76%
|
11.54%
|
11.75%
|
EPS
2 |
1.600
|
0.7800
|
1.250
|
1.830
|
2.040
|
1.390
|
1.800
|
1.980
|
1.020
|
1.690
|
1.893
|
1.952
|
2.005
|
2.010
|
2.099
|
Dividend per Share
2 |
0.3000
|
0.2950
|
0.3000
|
0.3000
|
0.3300
|
0.3300
|
0.3300
|
0.3300
|
0.3650
|
-
|
0.3660
|
0.3833
|
0.3986
|
0.3979
|
0.4308
|
Announcement Date
|
11/2/21
|
2/1/22
|
5/5/22
|
8/2/22
|
11/1/22
|
1/31/23
|
5/2/23
|
8/1/23
|
10/31/23
|
1/30/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
3,149
|
3,367
|
3,311
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
1,277
|
-
|
-
|
1,100
|
1,300
|
-
|
ROE (net income / shareholders' equity)
|
12.3%
|
9.65%
|
7.99%
|
12.2%
|
16.5%
|
11.6%
|
11.3%
|
10.7%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
49.10
|
53.40
|
56.40
|
46.50
|
49.90
|
56.10
|
62.80
|
70.60
|
Cash Flow per Share
|
-
|
2.930
|
6.770
|
7.170
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/4/20
|
2/4/21
|
2/1/22
|
1/31/23
|
1/30/24
|
-
|
-
|
-
|
Last Close Price
50.75
USD Average target price
58.6
USD Spread / Average Target +15.47% Consensus |
1st Jan change
|
Capi.
|
---|
| +12.23% | 9.74B | | +14.78% | 79.51B | | +6.49% | 50.22B | | +1.35% | 48.11B | | +6.55% | 39.71B | | +19.34% | 37.78B | | +2.84% | 30.07B | | -7.77% | 27.56B | | -18.42% | 24.71B | | +6.89% | 21.99B |
Other Life & Health Insurance
|